No changes were observed in the levels of cytokines that promote NK cell function in NSCLC patients, including IFN-γ, TNF-α, IL-1β, IL-2, and IL-12 (Fig. 2c). This evidence concerns the gene IL2 and non-small cell lung carcinoma.